Maximize Your Data Impact in 2024: Key Trends and Strategic Insights for Scientific R&D
The webinar, inspired by the LINUS 2024 State of Science report and featuring experts from Dotmatics and LINUS Group, will explore key 2024 trends in scientific R&D such as AI/ML adoption, automation, external partnerships, and data strategies to enhance drug discovery, streamline workflows, and drive innovation through effective data integration and prescriptive analytics.
As the scientific R&D sector continues to navigate the challenges and opportunities of 2024, the strategic use of data is more powerful than ever. This webinar, inspired by the LINUS 2024 State of Science report, is designed for lab directors, research directors, and senior strategy leaders. It will showcase the transformative power of data to enrich and enhance scientific productivity and efficiency.
Join Dotmatics and LINUS as we explore the latest trends and strategic innovations that are shaping a new era in scientific R&D. Our speakers—Alister Campbell, VP Science & Technology at Dotmatics; Natalie LaFranzo, VP of Strategy at LINUS Group; and Erin Legwold, Associate Strategist at LINUS Group—will guide us through some key results of the report and discuss real-world examples in the lab.
Key discussions will include:
- Significance of AI/ML adoption in accelerating drug discovery and development
- Role of automation in streamlining research processes and workflows
- Importance of external partnerships in expanding data access and insights
- Trends influencing investment and technology adoption in the life sciences
This webinar will provide actionable insights into how to harness data more effectively, driving innovation and productivity in your research initiatives. Discover the strategies that leading organizations are implementing to navigate data standardization, integration, and the transition from predictive analytics to prescriptive solutions. Learn about the tools and technologies that are enabling scientists to do more with less, turning data into a powerful asset for advancing scientific outcomes.
Featured Speakers
- Alister Campbell, VP Science & Technology, Dotmatics
- Natalie LaFranzo, VP of Strategy, LINUS Group
Natalie is an experienced commercial leader driven to build impactful and executable strategies. She earned her PhD in chemistry from Washington University in St. Louis. Her background includes interdisciplinary research experience spanning molecular biology, surface chemistry, and oncology, with a strong emphasis on next generation sequencing and molecular technologies. - Erin Legwold, Associate Strategist, LINUS Group
Erin's passion for discovery and connection has driven her work in research design, data analysis, and insight development at LINUS for over 2 years. Her past experience in social impact research and strategy has inspired her search for other impact opportunities in health, wellness, and life sciences. Erin manages and maintains the LINUS research network, leveraged to identify unique audiences in various markets and connect with the broader scientific community.
Event Details
- Date: 08 May 2024
- Time: 11:30 AM EST
- Format: Virtual
Related
Maximize Your Data Impact
The article discusses how R&D leaders can maximize the impact of their data by adopting AI/ML technologies, establishing robust data infrastructures, and leveraging automation and external partnerships, as highlighted by insights from Dotmatics' collaboration with LINUS and their State of Science survey revealing scientists' strategic shifts toward automation and partnerships amid scientific and economic challenges.
Simplify your laboratory workflow management with Dotmatics
Dotmatics offers a unified scientific R&D platform that streamlines laboratory workflow management by integrating various scientific applications, automating data extraction, cleaning, and harmonization into FAIR formats, thereby reducing manual data handling, enhancing collaboration, and accelerating the R&D cycle to help life sciences organizations bring new therapies to market faster.
Addressing Inefficient R&D Workflows
The blog discusses how legacy, fragmented R&D systems hinder innovation in complex, multi-domain scientific research by creating silos and inefficiencies, and presents Dotmatics’ unifying platform as a comprehensive solution that integrates diverse tools, data, and teams to enable smarter collaboration, governed data use, and AI-driven automation for faster, more rigorous innovation.
U.S. News & World Report: How AI is Transforming Medicine and Patient Care
A U.S. News & World Report article highlights how AI-driven platforms like Dotmatics Luma are revolutionizing healthcare and life sciences by enabling scientists to efficiently manage large datasets, accelerate drug discovery, and enhance patient care through real-time data integration and decision-making.
NBC Las Vegas: AI is Accelerating Drug Discovery and Vaccine Development
In an NBC Las Vegas interview, Phil Mounteney, VP of Science and Technology at Dotmatics, explains how AI is transforming drug discovery and vaccine development by accelerating research timelines, reducing costs, enhancing drug safety through advanced data analysis, and optimizing development pipelines for faster and more efficient medical breakthroughs post-COVID.
Gray TV Washington DC: AI helping scientists make drug breakthroughs
The Gray TV Washington DC feature highlights how scientists, including Christian Olsen of Dotmatics, are leveraging AI and machine learning to accelerate drug discovery and expedite bringing new drugs to market.